Proteome Sciences (LON:PRM) Shares Up 9% – Still a Buy?

Proteome Sciences plc (LON:PRMGet Free Report) shot up 9% during trading on Tuesday . The stock traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). 967,070 shares changed hands during trading, an increase of 496% from the average session volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).

Proteome Sciences Stock Up 3.5 %

The firm has a market capitalization of £9.65 million, a P/E ratio of -327.00 and a beta of 0.07. The company’s 50 day moving average is GBX 2.73 and its 200-day moving average is GBX 3.15.

About Proteome Sciences

(Get Free Report)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.

Featured Stories

Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.